BATON ROUGE, La., Feb. 15, 2018 — Amedisys, Inc. (NASDAQ:AMED), announced today that it will report results for the fourth quarter and year ended December 31, 2017 after the market closes on February 27, 2018. The Company will host an investor conference call to discuss these results at 12:00 p.m. ET on February 28, 2018.
To participate on the conference call, please call a few minutes before 12:00 p.m. ET to either (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll). A replay of the conference call will be available through March 28, 2018 by dialing (877) 660-6853 (Toll-Free) or (201) 612-7415 (Toll) and entering conference ID #13676051.A live webcast of the call will be accessible through our website on our Investor Relations section at the following web address: http://investors.amedisys.com.About Amedisys:Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. We partner with 3,000 hospitals and 59,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 17,500 employees, in 416 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 369,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.com.We use our company website as a channel of distribution for important company information. Important information, including press releases, investor presentations and financial information regarding the Company is routinely posted on and accessible on the “Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled “Investors” on our website home page. Visitors to our website can also register to receive automated e-mail and other notifications alerting them to when new information is made available on the Investor Relations subpage of our website. In addition, we make available on the Investor Relations subpage of our website (under the link “SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation, Nominating and Corporate Governance, Quality of Care and Compliance and Ethics Committees of our Board are also available on the Investor Relations subpage of our website (under the link “Corporate Governance”).Contact:
Latest posts by Jasmine Petters (see all)
- BioArctic receives regulatory approval in Estonia for a clinical study in patients with Complete Spinal Cord Injury - February 21, 2018
- RVC Continues Its Run as One of the Most Active Angel Groups in US - February 21, 2018
- Zealand Pharma reports completion of the first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia - February 21, 2018